4.6 Review

Coffee consumption and risk of prostate cancer: a systematic review and meta-analysis

期刊

BMJ OPEN
卷 11, 期 2, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2020-038902

关键词

epidemiology; prostate disease; nutrition

资金

  1. Natural Science Foundation of Liaoning Province of China [2019-MS-3608]
  2. 345 Talent Project of Shengjing Hospital of China Medical University [M0122]

向作者/读者索取更多资源

This study suggests that higher coffee consumption may be associated with a lower risk of prostate cancer, as shown in the systematic review and meta-analysis of cohort studies conducted.
Objectives To conduct a systematic review with meta-analysis of cohort studies to evaluate the association of coffee consumption with the risk of prostate cancer. Data sources PubMed, Web of Science and Embase were searched for eligible studies up to September 2020. Study selection Cohort studies were included. Data extraction and synthesis Two researchers independently reviewed the studies and extracted the data. Data synthesis was performed via systematic review and meta-analysis of eligible cohort studies. Meta-analysis was performed with the metan and glst commands in Stata 14.0. Main outcomes and measures Prostate cancer was the main outcome. It was classified as localised prostate cancer which included localised or non-aggressive cancers; advanced prostate cancer which included advanced or aggressive cancers; or fatal prostate cancer which included fatal/lethal cancers or prostate cancer-specific deaths. Results Sixteen prospective cohort studies were finally included, with 57 732 cases of prostate cancer and 1 081 586 total cohort members. Higher coffee consumption was significantly associated with a lower risk of prostate cancer. Compared with the lowest category of coffee consumption, the pooled relative risk (RR) was 0.91 (95% CI 0.84 to 0.98), I-2= 53.2%) for the highest category of coffee consumption. There was a significant linear trend for the association (p=0.006 for linear trend), with a pooled RR of 0.988 (95% CI 0.981 to 0.995) for each increment of one cup of coffee per day. For localised, advanced and fatal prostate cancer, the pooled RRs were 0.93 (95% CI 0.87 to 0.99), 0.88 (95% CI 0.71 to 1.09) and 0.84 (95% CI 0.66 to 1.08), respectively. No evidence of publication bias was indicated in this meta-analysis. Conclusions This study suggests that a higher intake of coffee may be associated with a lower risk of prostate cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Comparison of Sutureless and Conventional Laparoscopic Partial Nephrectomy: A Propensity Score-Matching Analysis

Feng Zhang, Shuang Gao, Yiqiao Zhao, Bin Wu, Xiaonan Chen

Summary: The study comparing sutureless and conventional laparoscopic partial nephrectomy found that sutureless approach can reduce operative time and warm ischemia time, with better postoperative renal function recovery and preservation of more renal parenchyma.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Association Between the Pretreatment Albumin-to-Alkaline Phosphatase Ratio and Clinical Outcomes in Patients With Bladder Cancer Treated With Radical Cystectomy: A Retrospective Cohort Study

Shijie Li, Shiyang Lu, Xuefeng Liu, Xiaonan Chen

Summary: This study found that the serum albumin-to-alkaline phosphatase ratio (AAPR) is significantly associated with the prognosis of bladder cancer patients receiving radical cystectomy, providing insights for clinical decision-making and risk stratification. The AAPR-based nomograms showed good predictive accuracy for overall survival, cancer-specific survival, and recurrence-free survival.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Prognostic Effect of Subclassification on Oncological Outcomes in Patients with Surgically Treated Localized Papillary Renal Cell Carcinoma: A Retrospective Propensity Score-matched Cohort Study

Shijie Li, Xuefeng Liu, Xiaonan Chen

Summary: This study compared the clinical and pathological characteristics and outcomes of different subtypes of papillary renal cell carcinoma (PRCC) and found that type 2 PRCC had significantly poorer survival rates. Smoking history and pathological characteristics were independent factors for predicting the oncological outcomes of PRCC patients.

JOURNAL OF CANCER (2022)

Article Oncology

Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients

Yiqiao Zhao, Zijia Tao, Lei Li, Jianyi Zheng, Xiaonan Chen

Summary: In this study, we developed a prognostic model based on gene expression profiles to predict biochemical recurrence (BCR) in prostate cancer patients. The model showed strong predictive ability and could be a valuable tool for clinical use and further research in understanding the mechanisms underlying prostate cancer.

BMC CANCER (2022)

Review Medicine, Research & Experimental

5-methylcytosine RNA methyltransferases and their potential roles in cancer

Mingyang Li, Zijia Tao, Yiqiao Zhao, Lei Li, Jianyi Zheng, Zeyu Li, Xiaonan Chen

Summary: In recent years, m(5)C RNA modification has been found to play a crucial role in regulating RNA metabolism and function, affecting cell proliferation, differentiation, apoptosis, and other biological processes. m(5)C modification is associated with the pathogenesis and progression of cancers, and abnormal expression of related genes can be used to predict patient prognosis.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Article Genetics & Heredity

Prognostic Characteristics and Immune Effects of N6-Methyladenosine and 5-Methylcytosine-Related Regulatory Factors in Clear Cell Renal Cell Carcinoma

Lei Li, Zijia Tao, Yiqiao Zhao, Mingyang Li, Jianyi Zheng, Zeyu Li, Xiaonan Chen

Summary: This study investigated the relationship between N-6-methyladenosine and 5-methylcytosine regulators and clear cell renal cell carcinoma and identified five potential biomarkers for future research.

FRONTIERS IN GENETICS (2022)

Article Medicine, General & Internal

Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study

Jianyi Zheng, Shijie Li, Yiqiao Zhao, Zijia Tao, Lei Li, Zeyu Li, Mingyang Li, Xiaonan Chen

Summary: This study successfully constructed and validated nomograms to predict overall survival (OS) and cancer-specific survival (CSS) for patients with chromophobe renal cell carcinoma (chRCC) after nephrectomy. The nomograms showed accurate discrimination and were proven to be better in accuracy and efficacy ability compared to the seventh tumor, node, and metastasis stage. These nomograms can assist clinical doctors in choosing individual treatment strategies for chRCC patients.

BMJ OPEN (2022)

Article Oncology

Risk factors and a predictive nomogram for hemodynamic instability during adrenalectomy for large pheochromocytomas and paragangliomas: A retrospective cohort study

Shijie Li, Zeyu Li, Jianyi Zheng, Xiaonan Chen

Summary: This study aimed to investigate risk factors for intraoperative hemodynamic instability (HDI) and construct a clinical model for predicting intraoperative HDI for large pheochromocytomas and paragangliomas (PPGLs) patients. Independent risk factors were identified and a predictive model was constructed, which showed good predictive power in the training and validation cohorts. This model can help in individualized pre-treatment decision-making.
Review Biochemistry & Molecular Biology

Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application

Mingyang Li, Lei Li, Jianyi Zheng, Zeyu Li, Shijie Li, Kefeng Wang, Xiaonan Chen

Summary: Renal cell carcinoma (RCC) is a common type of kidney cancer with unremarkable symptoms in early stages and low sensitivity to radiotherapy and chemotherapy. Liquid biopsy, an emerging non-invasive test, can measure patient biomarkers for diagnosis, prognostic assessment, treatment monitoring, and response evaluation. With rapid development and iteration of extraction and analysis technologies, liquid biopsy has become a low cost, high efficiency, and high accuracy clinical detection method. In this review, we comprehensively discuss the components, clinical applications, limitations, and future prospects of liquid biopsy in the past 5 years.

MOLECULAR CANCER (2023)

Article Medicine, General & Internal

Associations between lumbar bone mineral density, serum 25-hydroxyvitamin D and history of kidney stones in adults aged 30-69 years in the USA (NHANES 2011-2018)

Zeyu Li, Lei Li, Jianyi Zheng, Mingyang Li, Siyu Wu, Kerong Xin, Rong Li, Song Bai, Xiaonan Chen

Summary: This study aimed to investigate the relationship between kidney stone history and human bone health. Results showed a negative correlation between lumbar bone mineral density and kidney stone history, and an interaction between serum 25-hydroxyvitamin D and lumbar BMD regarding kidney stone formation. Therefore, maintaining high lumbar BMD and serum 25-hydroxyvitamin D levels may help prevent the occurrence of kidney stones.

BMJ OPEN (2023)

Review Medicine, Research & Experimental

Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications

Siyu Wu, Rong Li, Yuanhong Jiang, Jiazheng Yu, Jianyi Zheng, Zeyu Li, Mingyang Li, Kerong Xin, Yang Wang, Zhenqun Xu, Shijie Li, Xiaonan Chen

Summary: Liquid biopsy is an accurate method for determining molecular profiles in urothelial carcinoma (UC). It has the potential to play a crucial role in early diagnosis, treatment monitoring, and prognosis prediction, thereby contributing to precision medicine in UC management.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Cell Biology

Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway

Lei Li, Mingyang Li, Jianyi Zheng, Zeyu Li, Xiaonan Chen

Summary: This study reveals that NSUN5 is highly expressed in ccRCC and is associated with tumor immunity. The high-risk group responds poorly to immunosuppressive treatment and has lower stromal scores compared to the low-risk group. NSUN5 knockout reduces ccRCC cell proliferation and migration, while increasing apoptosis.

AGING-US (2023)

Review Biochemistry & Molecular Biology

Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer

Shijie Li, Kerong Xin, Shen Pan, Yang Wang, Jianyi Zheng, Zeyu Li, Xuefeng Liu, Bitian Liu, Zhenqun Xu, Xiaonan Chen

Summary: Bladder cancer is a global clinical challenge characterized by late presentation, poor prognosis, and low survival rates. Traditional methods for diagnosis and monitoring, such as cystoscopy and tissue biopsy, have limitations and high costs. In recent years, liquid biopsies, specifically blood-based ones, have emerged as highly efficient methods for discovering biomarkers and monitoring tumor progression. Several liquid biopsy biomarkers have shown promising results in clinical applications, including early detection, residual disease detection, recurrence prediction, and therapy response.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2023)

Article Biotechnology & Applied Microbiology

A united risk model of 11 immune-related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients

Zijia Tao, Enchong Zhang, Lei Li, Jianyi Zheng, Yiqiao Zhao, Xiaonan Chen

Summary: The study successfully established a unified prognostic risk model, incorporating clinical stage and immune-related gene pairs, to effectively assess the overall survival of ccRCC patients. The model showed high accuracy in predicting survival outcomes across multiple validation cohorts, demonstrating better performance than individual IRGP signatures. Immune infiltration analysis revealed higher abundance of certain immune cells in ccRCC patients with poor prognosis.

BIOENGINEERED (2021)

暂无数据